"Research Faculty - IM Medical Oncology (Open Rank/Track Faculty)"

The OSUCCC-James Pelotonia Institute for Immuno-Oncology (PIIO) is seeking innovative immune monitoring experts for research-track faculty positions in the Division of Medical Oncology within the Department of Internal Medicine; serves as co-investigator on sponsored research grants and co-author on original research publications; conceptualizes, plans, designs, implements and conducts research studies in the PIIOs Immune Monitoring and Discovery Platform (IMDP) in the following areas: Cellular Immuno-Oncology (Flow Cytometry), Tissue Immuno-Oncology (Multispectral Imaging), Molecular Immuno-Oncology (Immunogenomics); develops and writes grant proposals to seek and obtain funding to support research program; writes and publishes research in high quality peer reviewed, scientific journals; attends and makes presentations of research at national and international scientific conferences; develops national and international scholarly reputation; instructs and mentors junior scientists, doctoral and postdoctoral students, medical students, residents and fellow trainees; participates in division, department, college and university committees and initiatives.

Minimum Education/Experience Requirements:

Applicants must hold advanced degrees such as MD, DVM, PharmD, PhD, or MD/PhD. A postdoctoral fellowship in immunology, immuno-oncology, hematology, cancer genomics and/or pathobiology is required. Extensive experience leading or working with shared resource laboratories from one of these Technology Hubs is strongly preferred. Proven ability to write scientific reports and publish in scientific, peer-reviewed journals preferred; understanding of key components of grant writing and obtaining funding in support of research required; experience with administration of funded research required. Requires successful completion of a background check. Selected candidate may be requested to complete a pre-employment physical including a drug screen.

The PIIO is a comprehensive bench-to-bedside research initiative focused on harnessing the bodys immune system to fight cancer at all levels (https://cancer.osu.edu/piio). Launched in July 2019 as part of a $102 Million pledge from Pelotonia (pelotonia.org), the PIIO represents Ohio State's commitment to grow the exciting area of immuno-oncology. Led by founding director and renowned immunologist Zihai Li, MD, PhD, the PIIO builds upon a rich portfolio of active investigator-initiated IO clinical trials being conducted at the OSUCCC James.

Research in the PIIO centers on Systems IO (a systems-wide strategy to study the anti-cancer immune response holistically to discover the next IO breakthroughs and create effective cancer immunotherapies) and Translational IO (where we turn discoveries into new or improved cancer treatments and broaden the indications and patient populations that can be treated with cellular therapy). Our Immune Monitoring and Discovery Platform (IMDP) supports each center, providing comprehensive cell-based and molecule-based immunoassay services to support basic, translational, and clinical IO studies. The PIIOs Immuno-Oncology Informatics Group (IOIG) provides data analytics for flow and mass cytometry, bulk and single-cell RNA-Seq, spatial transcriptomics and imaging, neoantigen discovery, and more.

To apply: Send cover letter, CV, 2-3-page description of current and future research interests and contact information for three references via email to Tamra Brooks at tamra.brooks@osumc.edu.